Plaxgen is a Nanobiotechnology company dedicated to developing innovative technologies for effective diagnosis and drug discovery focused on plaque-associated diseases. Plaxgen’s proprietary and patent pending “Plaque Array” platform was developed for illuminating and detecting plaque particles related to origin and progression of cardiovascular and neurodegenerative diseases. The Flow cytometry based Plaque Array is a rapid screening method for testing in vitro cholesterol and amyloid plaque particles formation in blood (serum) samples. The Plaque Array is currently under clinical development for rapid and non-invasive diagnosis of atherosclerosis and Alzheimer’s disease.
